Acadia Pharmaceuticals Inc (ACAD) stock
ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3027% below fair value
$18.32−0.35 (-1.87%)
Close on Nov 17, 2026Market cap $3.16BP/E 8.3Yield –
Acadia Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Acadia Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was $160.32M, down 14.7% year over year. For fiscal 2025 it was $109.84M, down 30.4% from the year before. The highest annual figure on record is $157.72M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $109.84M | -30.4% |
| FY2024 | Dec 31, 2024 | $157.72M | +844.3% |
| FY2023 | Dec 31, 2023 | $16.70M | – |
| FY2022 | Dec 31, 2022 | -$114.04M | – |
| FY2021 | Dec 31, 2021 | -$125.66M | – |
| FY2020 | Dec 31, 2020 | -$136.17M | – |
| FY2019 | Dec 31, 2019 | -$151.13M | – |
| FY2018 | Dec 31, 2018 | -$167.47M | – |
| FY2017 | Dec 31, 2017 | -$217.76M | – |
| FY2016 | Dec 31, 2016 | -$208.41M | – |
| FY2015 | Dec 31, 2015 | -$121.80M | – |
| FY2014 | Dec 31, 2014 | -$66.43M | – |
| FY2013 | Dec 31, 2013 | -$31.77M | – |
| FY2012 | Dec 31, 2012 | -$21.63M | – |
| FY2011 | Dec 31, 2011 | -$19.90M | – |
| FY2010 | Dec 31, 2010 | -$10.70M | – |
| FY2009 | Dec 31, 2009 | -$13.73M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $100.78M | +57.6% |
| Q1 FY2026 | Mar 31, 2026 | $33.98M | +67.2% |
| Q4 FY2025 | Dec 31, 2025 | -$48.73M | -220.7% |
| Q3 FY2025 | Sep 30, 2025 | $74.29M | +17.5% |
| Q2 FY2025 | Jun 30, 2025 | $63.96M | +155.7% |
| Q1 FY2025 | Mar 31, 2025 | $20.32M | -30.1% |
| Q4 FY2024 | Dec 31, 2024 | $40.38M | -52.7% |
| Q3 FY2024 | Sep 30, 2024 | $63.25M | – |
| Q2 FY2024 | Jun 30, 2024 | $25.01M | +205.0% |
| Q1 FY2024 | Mar 31, 2024 | $29.08M | – |
| Q4 FY2023 | Dec 31, 2023 | $85.39M | – |
| Q3 FY2023 | Sep 30, 2023 | -$58.96M | – |
| Q2 FY2023 | Jun 30, 2023 | $8.20M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.93M | – |
| Q4 FY2022 | Dec 31, 2022 | -$23.85M | – |
| Q3 FY2022 | Sep 30, 2022 | -$727.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.13M | – |
| Q1 FY2022 | Mar 31, 2022 | -$76.33M | – |
| Q4 FY2021 | Dec 31, 2021 | -$23.12M | – |
| Q3 FY2021 | Sep 30, 2021 | -$17.06M | – |
| Q2 FY2021 | Jun 30, 2021 | -$25.33M | – |
| Q1 FY2021 | Mar 31, 2021 | -$60.15M | – |
| Q4 FY2020 | Dec 31, 2020 | -$27.49M | – |
| Q3 FY2020 | Sep 30, 2020 | -$22.79M | – |
| Q2 FY2020 | Jun 30, 2020 | -$36.88M | – |
| Q1 FY2020 | Mar 31, 2020 | -$49.00M | – |
| Q4 FY2019 | Dec 31, 2019 | -$29.71M | – |
| Q3 FY2019 | Sep 30, 2019 | -$18.85M | – |
| Q2 FY2019 | Jun 30, 2019 | -$38.40M | – |
| Q1 FY2019 | Mar 31, 2019 | -$64.18M | – |
| Q4 FY2018 | Dec 31, 2018 | -$39.08M | – |
| Q3 FY2018 | Sep 30, 2018 | -$42.28M | – |
| Q2 FY2018 | Jun 30, 2018 | -$40.88M | – |
| Q1 FY2018 | Mar 31, 2018 | -$45.24M | – |
| Q4 FY2017 | Dec 31, 2017 | -$29.90M | – |
| Q3 FY2017 | Sep 30, 2017 | -$58.40M | – |
| Q2 FY2017 | Jun 30, 2017 | -$58.90M | – |
| Q1 FY2017 | Mar 31, 2017 | -$70.56M | – |
| Q4 FY2016 | Dec 31, 2016 | -$61.19M | – |
| Q3 FY2016 | Sep 30, 2016 | -$49.26M | – |
See a number that looks wrong?